Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - CONTRA.
Topic:
Acute Coronary Syndromes: Post-Infarction Period
Speaker:
Professor R. Storey (Sheffield, GB)
Congress Presentation
About the speaker
Professor Robert Storey
University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
24
presentations
1
follower
9 more presentations in this session
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal PRO.
Speaker: Doctor A. Rubboli (Ravenna, IT)
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal CONTRA.
Speaker: Professor R. Storey (Sheffield, GB)
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough: Chairpersons conclusion
Access the full session
Controversies on anticoagulants post-MI antithrombotic treatment
Speakers:
Professor R. Storey, Doctor A. Rubboli, Doctor A. Rubboli, Professor R. Storey, Professor R. De Caterina
About the event
